Apotex Inc.
Chetan Dhotre serves as the Director of the Isotope Program at Canadian Nuclear Laboratories since January 2022. Additionally, Chetan is a member of the Board of Directors, Event Committee Chair, and Training Committee Member at PSG Pharmaceutical Sciences Group since 2016. Previously, Chetan held the position of Vice President of Operations at New Maple Holdings from 2019 to July 2023 and worked at Sanofi Pasteur from 2008 to 2019, where roles included Head of Engineering and Deputy Director of Projects. Chetan’s earlier experience includes positions at Honeywell as Operations Excellence Manager and Owens Corning as Operations Excellence Manager and Manufacturing Manager. Chetan holds an M.B.A. from the University of Toronto - Rotman School of Management and completed the Management Excellence Program at UCLA Anderson School of Management and Schulich School of Business - York University. Chetan earned a Bachelor of Engineering from Walchand Institute of Technology, Solapur.
This person is not in the org chart
This person is not in any teams
Apotex Inc.
3 followers
Apotex is a Canadian owned pharmaceutical company, and the largest producer of generic medicines in the country. Founded in 1974, the company has focused on research, development, manufacturing and distribution. Apotex has steadily grown to employ over 10,000 people around the world.Apotex Pharmachem is a global, fully integrated API R&Dand manufacturing organization with its headquarters located in Brantford, Ontario, and is a member of the Apotex group of companies. Apotex Pharmachem has multiple facilities around the world located in Canada, India, Mexico, and China. Learn more at www.ApotexPharmachem.com.